Botanix Pharmaceuticals Ltd logo

Botanix Pharmaceuticals Ltd

ASX:BOT (Australia)  
A$ 0.19 (-2.63%) Feb 21
At Loss
P/B:
10.89
Market Cap:
A$ 297.05M ($ 194.63M)
Enterprise V:
A$ 288.37M ($ 188.94M)
Volume:
4.85M
Avg Vol (2M):
2.71M
Also Trade In:
Volume:
4.85M
At Loss
Avg Vol (2M):
2.71M

Business Description

Description
Botanix Pharmaceuticals Ltd is a clinical-stage cannabinoid therapeutics company. The company's focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne. The majority of Revenue is Derived from Australia.
Name Current Vs Industry Vs History
Cash-To-Debt 320.31
Equity-to-Asset 0.92
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 92.09
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 36.36
9-Day RSI 48.28
14-Day RSI 52.06
12-1 Month Momentum % 121.52

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.42
Quick Ratio 5.75
Cash Ratio 5.44
Days Inventory 99999999.99
Days Sales Outstanding 799.1
Days Payable 99999999.99

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.5
Shareholder Yield % -7.23

Financials

ASX:BOT's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Botanix Pharmaceuticals Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 0.103
EPS (TTM) (A$) -0.008
Beta 1.96
Volatility % 90.53
14-Day RSI 52.06
14-Day ATR (A$) 0.008817
20-Day SMA (A$) 0.18275
12-1 Month Momentum % 121.52
52-Week Range (A$) 0.074 - 0.21
Shares Outstanding (Mil) 1,563.44

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Botanix Pharmaceuticals Ltd Filings

Filing Date Document Date Form
No Filing Data

Botanix Pharmaceuticals Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Botanix Pharmaceuticals Ltd Frequently Asked Questions

What is Botanix Pharmaceuticals Ltd(ASX:BOT)'s stock price today?
The current price of ASX:BOT is A$0.19. The 52 week high of ASX:BOT is A$0.21 and 52 week low is A$0.07.
When is next earnings date of Botanix Pharmaceuticals Ltd(ASX:BOT)?
The next earnings date of Botanix Pharmaceuticals Ltd(ASX:BOT) is .
Does Botanix Pharmaceuticals Ltd(ASX:BOT) pay dividends? If so, how much?
Botanix Pharmaceuticals Ltd(ASX:BOT) does not pay dividend.

Press Release

Subject Date
No Press Release